Table 3.
Overall frequency and comparison of etiological factors for suspected and MRI-proven CES.
| Variable | Characteristic | Overall, N = 256 | Suspected CES, N = 229 | MRI-proven, N = 27 | P-value |
|---|---|---|---|---|---|
| PMH of cancer diagnosis, or previous CES | Yes | 123 (48.05) | 112 (48.91) | 11 (40.74) | 0.549 |
| Hx of trauma in past | Yes | 55 (21.48) | 50 (21.83) | 5 (18.52) | 0.882 |
| Is there a PMH of previous CES | Yes | 27 (10.55) | 20 (8.73) | 7 (25.93) | 0.016 |
| Patient was given any information about cauda equina syndrome previously | Yes | 4 (1.56) | 3 (1.31) | 1 (3.70) | 0.898 |
| Instruction about changing consequences in delayed care | Yes | 158 (61.72) | 134 (58.52) | 24 (88.89) | 0.004 |
| Duration of symptoms | <72 h progressive symptom | 55 (21.48) | 52 (22.71) | 3 (11.11) | 0.137 |
| >2/52 | 93 (36.33) | 85 (37.12) | 8 (29.63) | ||
| 72 h–2 weeks/non-progressive symptom | 108 (42.19) | 92 (40.17) | 16 (59.26) | ||
| Post-micturition bladder volume (mL) | <100 | 50 (19.53) | 50 (21.83) | 0 (0.00) | <0.001 |
| 100–200 | 15 (5.86) | 15 (6.55) | 0 (0.00) | ||
| 200–400 | 7 (2.73) | 3 (1.31) | 4 (14.81) | ||
| 400 and above | 17 (6.64) | 8 (3.49) | 9 (33.33) | ||
| Not available | 167 (65.23) | 153 (66.81) | 14 (51.85) | ||
| Need of catheterization | Yes | 67 (26.17) | 58 (25.33) | 9 (33.33) | 0.507 |